A skull found in a well defied classification. Now it could help unravel an evolutionary mystery
An enigmatic skull recovered from the bottom of a well in northeastern China in 2018 sparked intrigue when it didn't match any previously known species of prehistoric human. Now, scientists say they have found evidence of where the fossil fits, and it could be a key piece in another cryptic evolutionary puzzle.
After several failed attempts, the researchers managed to extract genetic material from the fossilized cranium — nicknamed Dragon Man — linking it to an enigmatic group of early humans known as Denisovans. A dozen or so Denisovan fossilized bone fragments had previously been found and identified using ancient DNA. But the specimens' small size offered little idea of what this shadowy population of ancient hominins looked like, and the group has never been assigned an official scientific name.
Scientists typically consider skulls, with telltale bumps and ridges, the best type of fossilized remains to understand the form or appearance of an extinct hominin species. The new findings, if confirmed, could effectively put a face to the Denisovan name.
'I really feel that we have cleared up some of the mystery surrounding this population,' said Qiaomei Fu, a professor at the Institute of Paleontology and Paleoanthropology, part of the Chinese Academy of Sciences in Beijing, and lead author of the new research. 'After 15 years, we know the first Denisovan skull.'
Denisovans were first discovered in 2010 by a team that included Fu — who was then a young researcher at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany — from ancient DNA contained in a pinkie fossil found in Denisova Cave in the Altai Mountains of Russia. Additional remains unearthed in the cave, from which the group gets its name, and elsewhere in Asia continue to add to the still-incomplete picture.
The new research, described in two scientific papers published Wednesday, is 'definitely going to be among, if not the, biggest paleoanthropology papers of the year,' and will spur debate in the field 'for quite some time,' said Ryan McRae, a paleoanthropologist at the Smithsonian National Museum of Natural History in Washington, DC, who was not involved in the studies.
The findings could help fill in gaps about a time when Homo sapiens weren't the only humans roaming the planet — and teach scientists more about modern humans. Our species once coexisted for tens of thousands of years and interbred with both Denisovans and Neanderthals before the two went extinct. Most humans today carry a genetic legacy of those ancient encounters. Neanderthal fossils have been the subject of study for than a century, but scant details are known about our mysterious Denisovan cousins, and a skull fossil can reveal a great deal.
A laborer in the city of Harbin in northeastern China discovered the Dragon Man skull in 1933. The man, who was constructing a bridge over the Songhua River when that part of the country was under Japanese occupation, took home the specimen and stored it at the bottom of a well for safekeeping.
The man never retrieved his treasure, and the cranium, with one tooth still attached in the upper jaw, remained unknown to science for decades until his relatives learned about it before his death. His family donated the fossil to Hebei GEO University, and researchers first described it in a set of studies published in 2021 that found the skull to be at least 146,000 years old.
The researchers argued that the fossil merited a new species name given the unique nature of the skull, naming it Homo longi — which is derived from Heilongjiang, or Black Dragon River, the province where the cranium was found. Some experts at the time hypothesized that the skull might be Denisovan, while others have lumped the cranium in with a cache of difficult-to-classify fossils found in China, resulting in intense debate and making molecular data from the fossil particularly valuable.
Given the skull's age and backstory, Fu said she knew it would be challenging to extract ancient DNA from the fossil to better understand where it fit in the human family tree. 'There are only bones from 4 sites over 100,000 (years old) in the world that have ancient DNA,' she noted via email.
Fu and her colleagues attempted to retrieve ancient DNA from six samples taken from Dragon Man's surviving tooth and the cranium's petrous bone, a dense piece at the base of the skull that's often a rich source of DNA in fossils, without success.
The team also tried to retrieve genetic material from the skull's dental calculus — the gunk left on teeth that can over time form a hard layer and preserve DNA from the mouth. From this process, the researchers managed to recover mitochondrial DNA, which is less detailed than nuclear DNA but revealed a link between the sample and the known Denisovan genome, according to one new paper published in the journal Cell.
'Mitochondrial DNA is only a small portion of the total genome but can tell us a lot. The limitations lie in its relatively small size compared to nuclear DNA and in the fact that it is only inherited from the matrilineal side, not both biological parents,' McRae said.
'Therefore, without nuclear DNA a case could be made that this individual is a hybrid with a Denisovan mother, but I think that scenario is rather less likely than this fossil belonging to a full Denisovan,' he added.
The team additionally recovered protein fragments from the petrous bone samples, the analysis of which also suggested the Dragon Man skull belonged to a Denisovan population, according to a separate paper published Wednesday in the journal Science.
Together, 'these papers increase the impact of establishing the Harbin cranium as a Denisovan,' Fu said.
The molecular data provided by the two papers is potentially very important, said anthropologist Chris Stringer, research leader in human origins at London's Natural History Museum.
'I have been collaborating with Chinese scientists on new morphological analyses of human fossils, including Harbin,' he said. 'Combined with our studies, this work makes it increasingly likely that Harbin is the most complete fossil of a Denisovan found so far.'
However, Xijun Ni, a professor at the Institute of Vertebrate Paleontology and Paleoanthropology in Beijing who, along with Stringer, worked on the initial Dragon Man research but not the latest studies, said that he is cautious about the outcome of the two papers because some of the DNA extraction methods used were 'experimental.' Ni also said he finds it strange that DNA was obtained from surface dental calculus but not inside the tooth and petrous bone, given that the calculus appeared to be more exposed to potential contamination.
Nonetheless, he added that he thinks it is likely the skull and other fossils identified as Denisovan are from the same human species.
The goal in using a new extraction approach was to recover as much genetic material as possible, Fu explained, adding that the dense crystalline structure of dental calculus may help prevent the host DNA from being lost.
The protein signatures Fu and her team recovered indicated 'a Denisovan attribution, with other attributions very unlikely,' said Frido Welker, an associate professor of biomolecular paleoanthropology at the University of Copenhagen's Globe Institute in Denmark. Welker has recovered Denisovan proteins from other candidate fossils but was not involved in this research.
'With the Harbin cranium now linked to Denisovans based on molecular evidence, a larger portion of the hominin fossil record can be compared reliably to a known Denisovan specimen based on morphology,' he said.
With the Dragon Man skull now linked to Denisovans based on molecular evidence, it will be easier for paleoanthropologists to classify other potential Denisovan remains from China and elsewhere. McRae, Ni and Stringer all said they thought it was likely that Homo longi would become the official species name for Denisovans, although other names have been proposed.
'Renaming the entire suite of Denisovan evidence as Homo longi is a bit of a step, but one that has good standing since the scientific name Homo longi was technically the first to be, now, tied to Denisovan fossils,' McRae said. However, he added that he doubts the informal name of Denisovan is going anywhere anytime soon, suggesting it might become shorthand for the species, as Neanderthal is to Homo neanderthalensis.
The findings also make it possible to say a little more about what Denisovans might have looked like, assuming the Dragon Man skull belonged to a typical individual. According to McRae, the ancient human would have had very strong brow ridges, brains 'on par in size to Neanderthals and modern humans' but larger teeth than both cousins. Overall, Denisovans would have had a blocky and robust-looking appearance.
'As with the famous image of a Neanderthal dressed in modern attire, they would most likely still be recognizable as 'human,'' McRae said.
'They are still our more mysterious cousin, just slightly less so than before,' he added. 'There is still a lot of work to be done to figure out exactly who the Denisovans were and how they are related to us and other hominins.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
5 hours ago
- Medscape
Cervical Cancer Risk Overlooked After Age 65
TOPLINE: Analysis of over 2.1 million women in China revealed that those aged 65 years or older vs those younger than 65 years had significantly higher rates of high-risk human papillomavirus (hr-HPV) infection (13.67% vs 8.08%) and cervical cancer (0.092% vs 0.01%) although most guidelines recommend discontinuing screening for women aged 65 years or older with a normal screening history. METHODOLOGY: Researchers conducted a retrospective analysis of cervical cancer screening data from Shenzhen, China (2017-2023), to assess hr-HPV distribution and cervical intraepithelial neoplasia grade 2 or worse (CIN2+) prevalence in women aged 65 years or older vs those younger than 65 years. Data collection encompassed 628 healthcare facilities, including 496 community health centers, 94 hospitals, 11 maternal and child health hospitals, and 27 other medical facilities. Clinical records included demographic information, cytology results, HPV testing covering 14 hr-HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), and colposcopy/biopsy outcomes. Analysis included 2,152,766 complete records from an initial collection of 2,580,829, yielding an 83.4% data validity rate. TAKEAWAY: Analysis of 2,152,766 records revealed that women aged 65 years or older (n = 17,420; 0.81%) vs those younger than 65 years showed higher hr-HPV prevalence (13.67% vs 8.08%), CIN2+ detection rate (0.333% vs 0.155%), and cancer rate (0.092% vs 0.01%; P for all < .001). Single, double, and triple hr-HPV infections were found in 10.56%, 2.32%, and 0.57% of women aged 65 years or older, with CIN2+ detection rates of 2.01%, 2.73%, and 4.04%, respectively, all exceeding rates in those younger than 65 years (P < .001). A significant dose-response relationship emerged between hr-HPV infections and CIN2+ risk in women aged 65 years or older (P for trend < .001), with odds ratios being 55.86 (95% CI, 21.81-143.07), 65.95 (95% CI, 22.63-192.18), and 85.45 (95% CI, 24.15-302.35) for single, double, and triple infections, respectively. IN PRACTICE: 'Currently, there is a significant global gap in cervical cancer prevention for older women, and urgent action is needed. First, screening and early diagnosis for women aged ≥ 65 should be strengthened, including affordable screening services and age-appropriate technologies to detect and treat precancerous lesions. Additionally, community engagement, health education, and media campaigns can raise awareness of cervical cancer risks and prevention among older women, encouraging active participation in screening programs,' authors of the study wrote. SOURCE: The study was led by Zichen Ye, He Wang, and Yingyu Zhong, who served as joint first authors. It was published online in Gynecology and Obstetrics Clinical Medicine. LIMITATIONS: The study faced several limitations despite using high-quality, large-sample, real-world cervical cancer screening data collected over 7 years in Shenzhen. Because women aged 65 years or older were not included in the national target screening population, participants may have had symptoms or concerns, introducing potential selection bias. The low number of hr-HPV infections in this age group led to some results trending toward extremes, affecting result stability. Additionally, data from a single region in China limited generalizability to other populations. The researchers could not obtain specific information about the types of cytologic detection products and HPV genotyping products used, which may have affected result precision and comparability. DISCLOSURES: The study was supported by the Sanming Project of Medicine in Shenzhen (SZSM202211032). The authors reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
15 hours ago
- Yahoo
Asian Market Insights: 3 Stocks That Investors Might Be Undervaluing
As global markets respond to easing trade tensions and positive economic signals, Asian indices have shown resilience, with notable gains in China and Japan. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities amidst the broader market optimism. Name Current Price Fair Value (Est) Discount (Est) T'Way Air (KOSE:A091810) ₩2025.00 ₩4024.62 49.7% Suzhou Zelgen BiopharmaceuticalsLtd (SHSE:688266) CN¥111.64 CN¥222.46 49.8% SIGMAXYZ Holdings (TSE:6088) ¥1221.00 ¥2440.83 50% Shanghai OPM Biosciences (SHSE:688293) CN¥43.21 CN¥85.97 49.7% Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust (SET:PROSPECT) THB7.20 THB14.35 49.8% Maxscend Microelectronics (SZSE:300782) CN¥69.87 CN¥139.59 49.9% KeePer Technical Laboratory (TSE:6036) ¥3375.00 ¥6748.76 50% Good Will Instrument (TWSE:2423) NT$43.40 NT$86.69 49.9% Forum Engineering (TSE:7088) ¥1195.00 ¥2373.59 49.7% Duk San NeoluxLtd (KOSDAQ:A213420) ₩33600.00 ₩66906.69 49.8% Click here to see the full list of 268 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: Genscript Biotech Corporation is an investment holding company involved in the manufacture and sale of life science research products and services across the United States, Europe, Mainland China, Asia Pacific, and internationally, with a market cap of HK$33.16 billion. Operations: The company's revenue is primarily derived from Life Science Services and Products ($454.95 million), Biologics Development Services ($95.02 million), and Industrial Synthetic Biology Products ($53.69 million). Estimated Discount To Fair Value: 31.1% Genscript Biotech is trading at HK$15.22, significantly below its estimated fair value of HK$22.09, suggesting it may be undervalued based on cash flows. Recent payments totaling US$213.8 million from ProBio bolster its cash reserves, enhancing financial stability and core competencies. While earnings are forecast to grow substantially at 65.8% per year and revenue growth outpaces the Hong Kong market, a low return on equity of 7.1% in three years presents a potential concern for investors seeking high returns. Our expertly prepared growth report on Genscript Biotech implies its future financial outlook may be stronger than recent results. Dive into the specifics of Genscript Biotech here with our thorough financial health report. Overview: Suzhou Nanomicro Technology Co., Ltd. manufactures and supplies spherical, mono-disperse particles for various industries worldwide, with a market cap of CN¥9.13 billion. Operations: The company's revenue segments include the production and distribution of spherical, mono-disperse particles for diverse industrial applications globally. Estimated Discount To Fair Value: 15.5% Suzhou Nanomicro Technology is trading at CN¥22.77, below its estimated fair value of CN¥26.96, indicating potential undervaluation based on cash flows. Earnings are expected to grow significantly at 37.9% per year, outpacing the broader Chinese market's growth rate. Recent financial results show revenue increased to CN¥188.59 million from CN¥154.1 million a year ago, with net income rising to CN¥29.22 million from CN¥16.89 million, supporting its growth trajectory despite a forecasted low return on equity of 11%. The analysis detailed in our Suzhou Nanomicro Technology growth report hints at robust future financial performance. Click here and access our complete balance sheet health report to understand the dynamics of Suzhou Nanomicro Technology. Overview: SBS Holdings, Inc. offers logistics services both in Japan and internationally, with a market cap of ¥126.90 billion. Operations: The company generates revenue from its Logistics Business, which accounts for ¥429.82 billion, and its Real Estate Business, contributing ¥10.09 billion. Estimated Discount To Fair Value: 35.5% SBS Holdings, trading at ¥3195, is significantly undervalued with a fair value estimate of ¥4956.46 according to discounted cash flow analysis. Despite profit margins declining from 1.9% to 1.3%, earnings are projected to grow at 22.44% annually, surpassing the Japanese market growth rate of 7.5%. However, the dividend yield of 2.66% isn't well covered by free cash flows and debt coverage by operating cash flow remains weak amidst planned strategic acquisitions like Bridgestone Logistics Co., Ltd.'s stock. In light of our recent growth report, it seems possible that SBS Holdings' financial performance will exceed current levels. Click here to discover the nuances of SBS Holdings with our detailed financial health report. Unlock our comprehensive list of 268 Undervalued Asian Stocks Based On Cash Flows by clicking here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1548 SHSE:688690 and TSE:2384. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Scientists Found a Third State of Life. It Begins After Death.
What if there's a third state between life and death? And what if your cells are... conscious? Mind-blowing new research shows that, at least for some cells, death isn't the end, but the beginning of something entirely unexpected—and it all manifests in the form of strange little creatures called xenobots. Watch Pop Mech editors Andrew Daniels and John Gilpatrick dive into these tiny clusters of frog stem cells that scientists have designed to move, heal, and even organize on their own. They're not technically alive, but they're also not completely dead. Andrew and John unpack how these 'living robots' challenge our understanding of evolution, consciousness, and even what it means to be human. Along the way, they raise a wild possibility: Could the cells in your body think for themselves? Does consciousness exist not just in brains, but in tissues and organs? Some scientists say yes. Others call it pseudoscience. For now, the debate rages on. Watch the full episode above now, and find more installments of the Astounding Pop Mech Show on You Might Also Like The Do's and Don'ts of Using Painter's Tape The Best Portable BBQ Grills for Cooking Anywhere Can a Smart Watch Prolong Your Life?